School of Engineering

The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee, BS; Simone Calò, PhD; and Pietro Valdastri, PhD. (hoto by Susan Urmy)

VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.

Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.

Vanderbilt study uses AI to speed mpox drug trials

A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

Faculty, students to honor late professor Matthew Walker III in virtual memorial service on May 8

Faculty, students, administrators and friends of the School of Engineering and School of Medicine will hold a memorial to honor professor and mentor Matthew Walker III. Walker was a beloved professor and mentor who developed and taught Vanderbilt University’s biomedical engineering design curriculum and served as the associate director of the Medical Innovators Development Program. Walker died suddenly on April 24.

Mias Pretorius, MBChB, MSCI, chief of Cardiothoracic Anesthesiology at Vanderbilt University Medical Center (VUMC), models one of the face shields he and his family assembled to provide back-up personal protective equipment (PPE).

Physicians, engineering students, families and friends construct DIY face shields

As the number of COVID-19 infections continues to grow, Nashville resident Kobie Pretorius was searching for some way to provide meaningful help to others. And she realized her apprehension was spiking each morning as her husband went out the door for work.

New tool may speed antibody, vaccine research

Study aims to predict treatment response in epilepsy patients

With the aid of $2.5 million in funding from the National Institutes of Health (NIH), Vanderbilt researchers are on a quest to develop early biomarkers of treatment outcomes for patients with temporal lobe epilepsy based on their individual brain networks.

1 2 3 5